Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patients

Bacteria of the genus <i>Aeromonas</i> are widely distributed in water bodies around the world. Some <i>Aeromonas</i> species have been identified as human pathogens causing intestinal and a variety of extraintestinal infections. In Germany, information on diseases caused by <i>Aeromonas</i> is rare, because <i>Aeromonas</i> infections are not notifiable in Germany. To address this information gap and gain better insights, a successful collaboration with human medical diagnostic laboratories within Germany was established and several <i>Aeromonas</i> isolates from diseased patients were sent to the <i>Aeromonas</i> laboratory of the German Federal Institute for Risk Assessment. 52 clinical <i>Aeromonas</i> isolates, of which anonymized patients' data were available, were selected for further characterization by MALDI-TOF MS, biochemical testing, and whole genome sequencing (WGS). Nearly half of the isolates were from patients older than 60 years, whereas only four isolates were from patients aged up to 10 years. 30 isolates originated from stools of patients with diarrhea/(gastro-)enteritis and 22 strains were from patients with diverse extraintestinal infections, such as wound infection, septicemia, bursitis, abscesses, cholangitis, urinary tract infections, and pneumonia. Taxonomical identification revealed following predominant species: <i>A. veronii</i> biovar <i>sobria</i> (18 isolates), <i>A. caviae</i> (17 isolates), and <i>A. hydrophila</i> (nine isolates). Two <i>A. salmonicida</i> isolates and one isolate each of <i>A. dhakensis, A. bestiarum,</i> and <i>A. encheleia</i> were also identified. Three closely related intestinal isolates could not be assigned to a recognized <i>Aeromonas</i> species. The clustering of strains based on virulence factor profile resulted in a grouping that closely resembles the clustering of the phylogenetic tree suggesting that the profiles are specific for each species. Our study on clinical <i>Aeromonas</i> isolates characterizes for the first time human pathogenic strains isolated in Germany. These bacteria are important microorganisms within the One Health context because of their ubiquitous presence in the environment and as a cause of opportunistic infections in humans and animals. Infections caused by <i>Aeromonas</i> bacteria show a seasonality with increased infection rates in warmer periods. In view of climate change, <i>Aeromonas</i> bacteria are regarded as emerging pathogens and research is required to determine the reservoirs in One Health sources from which human infections may arise.

Authors

Institutions

Publication Details

Journal
Frontiers in Microbiology
Published
2024-12-18
DOI
https://doi.org/10.3389/fmicb.2024.1498180
Citations
14
Primary Topic
Aquaculture disease management and microbiota
Type
article
Field-Weighted Citation Impact
3.37

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patients

Eckhard Strauch, Carlus Deneke, Martin Richter, Maria Borowiak et al.
14 citations
Frontiers in Microbiology
Aquaculture disease management and microbiota
3.37
article

Emerging Aeromonas spp. infections in Europe: characterization of human clinical isolates from German patients

Eckhard Strauch, Carlus Deneke, Martin Richter, Maria Borowiak, Keike Schwartz
article en
14 citations

Abstract

Bacteria of the genus <i>Aeromonas</i> are widely distributed in water bodies around the world. Some <i>Aeromonas</i> species have been identified as human pathogens causing intestinal and a variety of extraintestinal infections. In Germany, information on diseases caused by <i>Aeromonas</i> is rare, because <i>Aeromonas</i> infections are not notifiable in Germany. To address this information gap and gain better insights, a successful collaboration with human medical diagnostic laboratories within Germany was established and several <i>Aeromonas</i> isolates from diseased patients were sent to the <i>Aeromonas</i> laboratory of the German Federal Institute for Risk Assessment. 52 clinical <i>Aeromonas</i> isolates, of which anonymized patients' data were available, were selected for further characterization by MALDI-TOF MS, biochemical testing, and whole genome sequencing (WGS). Nearly half of the isolates were from patients older than 60 years, whereas only four isolates were from patients aged up to 10 years. 30 isolates originated from stools of patients with diarrhea/(gastro-)enteritis and 22 strains were from patients with diverse extraintestinal infections, such as wound infection, septicemia, bursitis, abscesses, cholangitis, urinary tract infections, and pneumonia. Taxonomical identification revealed following predominant species: <i>A. veronii</i> biovar <i>sobria</i> (18 isolates), <i>A. caviae</i> (17 isolates), and <i>A. hydrophila</i> (nine isolates). Two <i>A. salmonicida</i> isolates and one isolate each of <i>A. dhakensis, A. bestiarum,</i> and <i>A. encheleia</i> were also identified. Three closely related intestinal isolates could not be assigned to a recognized <i>Aeromonas</i> species. The clustering of strains based on virulence factor profile resulted in a grouping that closely resembles the clustering of the phylogenetic tree suggesting that the profiles are specific for each species. Our study on clinical <i>Aeromonas</i> isolates characterizes for the first time human pathogenic strains isolated in Germany. These bacteria are important microorganisms within the One Health context because of their ubiquitous presence in the environment and as a cause of opportunistic infections in humans and animals. Infections caused by <i>Aeromonas</i> bacteria show a seasonality with increased infection rates in warmer periods. In view of climate change, <i>Aeromonas</i> bacteria are regarded as emerging pathogens and research is required to determine the reservoirs in One Health sources from which human infections may arise.

Frontiers in MicrobiologyVol. 15
Federal Institute for Risk Assessment (DE)
Bundesinstitut für Risikobewertung
Clean water and sanitation
Openalex Percentile: Top 7%
Aquaculture disease management and microbiota
3.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.